05 Compliance

The regulatory file for riboflavin 5-phosphate

Technical document 05 · Reviewed 2026-11-20 · Riboflavin 5-Phosphate

On this page
  1. What the file contains
  2. European Union
  3. United States
  4. United Kingdom
  5. Contaminants and limits
  6. Claims and the label
  7. Documents for the file
  8. Checklist before the first order

Riboflavin 5-phosphate is sold as the free acid (CAS 146-17-8) or the sodium salt (CAS 130-40-5). The EU food-supplement Annex I and the E 101(ii) additive specification are written around riboflavin-5'-phosphate, sodium; a free-acid lot is a different entry question. The buyer's regulatory team confirms the route for the destination, and this page lists the documents and checks that belong in the file.

In one line

The file has to answer one question before the limits: is the material the free acid or the sodium salt, and which entry does the destination name?

What the file contains

A riboflavin 5-phosphate file holds four records: the current specification for the free acid or the sodium salt, the certificate that released the lot, the contaminant and label rules for the finished dose, and the change history for source, process and pack. The COA covers one lot, the TDS describes the specification and the SDS covers handling; none decides which market entry the destination accepts.

Put the form and CAS number on the first page of the file. The free acid and the sodium salt have different CAS numbers and different molecular weights, and only the sodium salt is named in the EU supplement Annex I. A file that says only “riboflavin 5-phosphate” has left the first question open.

The pack also has to carry the allergen and GMO statements, the origin record, the residual-solvent statement and any declaration the customer's market requires. When one of these is absent for the lot, identify it while the quotation is open. A missing document is far easier to obtain before dispatch than after the container reaches port.

European Union

The EU food-supplement route sits on Directive 2002/46/EC. Annex I lists the vitamin forms that may be used, and for vitamin B2 it names riboflavin and riboflavin-5'-phosphate, sodium. The free acid is not the named sodium form. That is a form question for the buyer's regulatory team, not a conclusion this page can make for a destination.

The additive side is separate. The colour additive group is E 101: riboflavin is E 101(i) and riboflavin-5'-phosphate is E 101(ii) in Regulation (EC) No 1333/2008; the specifications in Regulation (EU) No 231/2012 describe the sodium salt, with the formula C17H20N4NaO9P·2H2O. The additive entry is a colour route, not a supplement vitamin route. Do not cite E 101(ii) as the supplement authorisation.

Labelling follows Regulation (EU) No 1169/2011: riboflavin is declared in mg and as a percentage of the 1.4 mg NRV. Contaminants follow Regulation (EU) 2023/915. Check the current consolidated text; the entries and the limits are amended from time to time.

United States

In the US, the question is how the ingredient is positioned in a dietary supplement and whether the finished product's labeling fits that position. Riboflavin is an essential vitamin with a Daily Value of 1.3 mg; the Supplement Facts panel declares riboflavin, and the ingredient statement names the source. The phosphate form is not declared as the nutrient itself.

Whoever places the ingredient in the supplement names the legal basis and the document behind it; the buyer then checks that the same basis reaches the finished product and its claim. A structure/function statement stands on its own substantiation and the DSHEA disclaimer. Certificate review stops at the material, and no label or claim sign-off is included. This page asserts no NDI status for either form.

United Kingdom

Great Britain runs a separate supplement and labelling regime, while Northern Ireland stays inside the EU framework, which includes Annex I of Directive 2002/46/EC. Which one governs depends on the delivery address. The buyer's regulatory team should record that choice on the order, so the label wording and the entry cited can be audited later.

Because the EU entry names the sodium salt, a free-acid lot should not be assumed to travel under it into Northern Ireland. The same question goes to the Great Britain file, which has its own list. Confirm before the pack is labelled, not after it is shipped.

Contaminants and limits

Contaminant compliance is worked out on the finished dose, not on the drum alone. The table below gives a starting point for a food-supplement file; the destination's current text and the daily dose set the final limit.

Contaminant limits to confirm for the finished product
ParameterReference to confirmWhat the file should show
Lead (Pb)3.0 mg/kg in the supplementLot result, method, limit and the finished-product calculation
Cadmium (Cd)1.0 mg/kg in the supplementLot result and any category exception that applies
Mercury (Hg)0.10 mg/kg in the supplementLot result and method
Arsenic (As)Customer or market limitThe agreed limit and the method, stated on the certificate

Convert the lot result to the finished product before comparing it with the limit. A drum result and a capsule result are different numbers, and a limit that is met in the powder can be missed in the dose. Record the calculation in the file.

Claims and the label

In the EU, the authorised riboflavin claims are on the Register under Regulation (EC) No 1924/2006. The label may use only the authorised wording for the nutrient, and the wording is tied to the nutrient, not to the phosphate form. This page itself makes no health claim.

In the US, a structure/function statement needs substantiation and the DSHEA disclaimer. No disease claim is open in either market. A certificate supports the material, not the claim; a claim revision never reopens the specification.

Keep the claim file separate from the specification file. A change to the claim wording does not change the assay, and a change to the form does not automatically carry the claim. The riboflavin page covers the parent nutrient; this page covers the phosphate source.

Documents for the file

The buyer's file needs the COA with the HPLC assay and its basis, the HPLC/UV identity, loss on drying, pH, the metal panel and the micro count. Add phosphorus by ICP-OES to confirm the phosphate, and sodium by ICP-OES if the sodium salt is the form. The specification must name the form and the basis; an as-is figure and a dried figure are not interchangeable.

Add the TDS, SDS, allergen and GMO statements, the origin record, the residual-solvent statement, the stability summary for the pack and the market statement for the destination. If the EU supplement route applies, the file should record why the form matches Annex I or what the buyer's team decided. The product hub carries the catalog specification.

Checklist before the first order

  • The specification revision, CAS number and named form sit on one sheet.
  • COA, TDS, SDS, allergen and GMO declarations, origin and residual-solvent statements are on file.
  • Phosphorus, and sodium where the salt is claimed, back the declared form.
  • Metal results are converted to the finished dose before the limit check.
  • Destination label and claim wording have had a regulatory review.
  • Source, process and pack changes run through change control.
  • Quotation, specification and certificate cite the same revision.

The quality page describes the release file; the identity page covers the analytical evidence; the methods library gives the test references.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation